II. Definition

  1. Metabolic disorder of carbohydrate economy
  2. Deficiency of pancreatic beta cell Insulin secretion
  3. Resistance to Insulin effect peripherally

III. Epidemiology (U.S. statistics for 2004 per ADA)

  1. Prevalence
    1. Type I Diabetes Mellitus: 750,000
    2. Type II Diabetes Mellitus: 13 million
    3. Gestational Diabetes: 135,000
    4. Undiagnosed with diabetes: 5.2 million
  2. Incidence
    1. Type 1: 30,000 new cases per year
    2. Type 2: 850,000 new cases per year
    3. Gestational Diabetes Mellitus: 4% of all pregnancies
    4. Fastest growing groups
      1. Ages 30 to 39 years
      2. Type II Diabetes in children

IV. Types

  1. Type I Diabetes Mellitus
    1. Juvenile Diabetes Mellitus
    2. Insulin Dependent Diabetes Mellitus (IDDM)
  2. Type II Diabetes Mellitus
    1. Adult onset Diabetes Mellitus
    2. Non-Insulin Dependent Diabetes Mellitus (NIDDM)
    3. Pediatric Type II Diabetes Mellitus (Pediatric NIDDM)
    4. Maturity onset Diabetes of youth (MODY)

V. Symptoms

  1. Classic (75% of cases of Type I Diabetes Mellitus)
    1. Polyuria or nocturia
    2. Polydipsia
    3. Unexplained Weight Loss
  2. Other symptoms
    1. Increased appetite
    2. Blurred vision
    3. Frequent Urinary Tract Infections
    4. Frequent yeast infections
    5. Fatigue
    6. Dry or pruritic skin
    7. Numbness or tingling in the extremities

VI. Diagnosis: Two of the following

  1. See Diabetes Screening
  2. Random Serum Glucose
    1. Serum Glucose over 200 mg/dl with symptoms
  3. Fasting Serum Glucose
    1. Serum Glucose exceeds 126 mg/dl on 2 different days
  4. Postprandial Glucose (2 hours post meal)
    1. Serum Glucose over 200 mg/dl
    2. Precedes Fasting Glucose increase
    3. More predictive of Diabetes Mellitus Complications
  5. Casual Plasma Glucose (random Glucose)
    1. Same criteria as postprandial Glucose
  6. Oral Glucose Tolerance Test (OGGT)
    1. Two hour Glucose Tolerance Test (75 gram) >200 mg/dl
    2. Consider in patients with Insulin Resistance
      1. Patients with pre-diabetes to qualify for education
  7. Hemoglobin A1C
    1. Hemoglobin A1C >6.5%

VII. Differential Diagnosis: Hyperglycemia

  1. See Hyperglycemia
  2. Stress response
    1. Blood Glucose typically <200 mg/dl
  3. Non-diabetic patient following a large meal
    1. Blood Glucose typically <160 mg/dl

VIII. Labs: Other monitoring

  1. Home Serum Glucose monitoring
    1. Over 50% of values should fall in target range

IX. Management: Severe Hyperglycemia at diagnosis

  1. Strongly consider Insulin at onset if severe Hyperglycemia
  2. Criteria
    1. Blood Glucose >300 mg/dl
    2. Hemoglobin A1C >9.0
  3. Protocol based on Urine Ketones
    1. Urine Ketones positive
      1. Evaluate for Diabetic Ketoacidosis
      2. Serum beta hydroxybutyrate (Serum Ketones) positive in Diabetic Ketoacidosis
      3. Basic metabolic panel findings suggestive of Diabetic Ketoacidosis
        1. Decreased serum bicarbonate
        2. Increased Anion Gap suggests
    2. Urine Ketones negative
      1. Confirm adequate hydration
        1. Consider Intravenous Fluids
      2. Type I vs Type II is not critical initially
        1. Both are given Insulin at this Hyperglycemia level
        2. Type II suspected
          1. Consider adding Metformin if normal Renal Function
            1. Start Metformin 500 mg orally daily to twice daily
          2. Insulin can likely be weaned later
            1. Glucose toxicity causes low Insulin level
            2. Endogenous Insulin will later normalize
      3. Start Lantus Insulin at 10 to 14 units SQ today
        1. Low risk of Hypoglycemia
        2. Alternative for a stable, asymptomatic patient with suspected Type II Diabetes (e.g. Emergency Department)
          1. Metformin might be started without Insulin
          2. Close interval follow-up, as persistent severe Hyperglycemia may be poorly responsive to oral agents initially
      4. Teach Glucose testing, Insulin injection today
        1. Formal Diabetic Education within 1 week
        2. Consider endocrinology Consultation later
      5. Give prescriptions today
        1. Meter, strips, lancets, Insulin, syringes

X. Management: Initial Education

  1. Key Topics
    1. See Diabetes Mellitus Glucose Management
    2. See Diabetes Mellitus Education
  2. Type specific Diabetes Information
    1. See Type I Diabetes Mellitus
    2. See Type II Diabetes Mellitus
  3. Adjunctive Management
    1. See Prevention of Diabetes Mellitus Complications
    2. See Hypertension in Diabetes Mellitus
    3. See Coronary Artery Disease Prevention in Diabetes
    4. See Diabetic Nephropathy
    5. See Tobacco Cessation
    6. See Low Fat Diet
    7. See AntiHyperlipidemic
    8. See Obesity Management
    9. Weight loss
    10. Aspirin (Guidelines as of 2012)
      1. Has historically been considered in all diabetic patients or starting at age 45 years in men and age 55 years in women
      2. Aspirin does not increase risk of Retinal Hemorrhage
      3. Indications for low dose Aspirin 81 mg daily (Framingham risk >10%, no vascular disease, and no Bleeding Diathesis)
        1. Males over age 50 years or females over age 60 years and
        2. One additional Cardiovascular Risk Factor
          1. Tobacco abuse
          2. Hypertension
          3. Dyslipidemia
          4. Albuminuria
          5. Family History of premature cardiovascular death
      4. Indications for Clopidogrel (Plavix) 75 mg daily
        1. Known cardiovascular disease
    11. Consider ACE Inhibitor in all diabetic patients
      1. See Diabetic Nephropathy
      2. Indications are more
      3. Use low dose (2.5 to 5 mg) in normotensive patient
    12. Lipid disorders
      1. See Coronary Artery Disease Prevention in Diabetes
      2. See Low Fat Diet
      3. See AntiHyperlipidemic

Images: Related links to external sites (from Bing)

Related Studies (from Trip Database) Open in New Window

Ontology: Diabetes Mellitus (C0011849)

Definition (CHV) diabetes mellitus
Definition (CHV) diabetes mellitus
Definition (CHV) diabetes mellitus
Definition (CHV) diabetes mellitus
Definition (CHV) diabetes mellitus
Definition (CHV) diabetes mellitus
Definition (MEDLINEPLUS)

Diabetes is a disease in which your blood glucose, or blood sugar, levels are too high. Glucose comes from the foods you eat. Insulin is a hormone that helps the glucose get into your cells to give them energy. With type 1 diabetes, your body does not make insulin. With type 2 diabetes, the more common type, your body does not make or use insulin well. Without enough insulin, the glucose stays in your blood.

Over time, having too much glucose in your blood can cause serious problems. It can damage your eyes, kidneys, and nerves. Diabetes can also cause heart disease, stroke and even the need to remove a limb. Pregnant women can also get diabetes, called gestational diabetes.

A blood test can show if you have diabetes. Exercise, weight control and sticking to your meal plan can help control your diabetes. You should also monitor your glucose level and take medicine if prescribed.

NIH: National Institute of Diabetes and Digestive and Kidney Diseases

Definition (NCI) A metabolic disorder characterized by abnormally high blood sugar levels due to diminished production of insulin or insulin resistance/desensitization.
Definition (NCI_NCI-GLOSS) A disease in which the body does not control the amount of glucose (a type of sugar) in the blood and the kidneys make a large amount of urine. This disease occurs when the body does not make enough insulin or does not use it the way it should.
Definition (NCI_CDISC) A metabolic disorder characterized by abnormally high blood sugar levels due to diminished production of insulin or insulin resistance/desensitization.
Definition (CSP) heterogeneous group of disorders that share glucose intolerance in common.
Definition (MSH) A heterogeneous group of disorders characterized by HYPERGLYCEMIA and GLUCOSE INTOLERANCE.
Concepts Disease or Syndrome (T047)
MSH D003920
ICD9 250
ICD10 E10-E14.9 , E14, E11, E08-E13
SnomedCT 191044006, 267467004, 154671004, 73211009
LNC MTHU020781, LA14291-1
English Diabetes, Diabetes Mellitus, DIABETES MELLITUS, Unspecified diabetes mellitus, diabetes mellitus, diabetes mellitus (diagnosis), DM, Diabetes mellitus NOS, diabetes NOS, Diabetes Mellitus [Disease/Finding], diabete mellitus, diabetes, disorder diabetes mellitus, diabetes (DM), diabetes mellitus (DM), Diabetes mellitus (E08-E13), Diabetes mellitus, DM - Diabetes mellitus, Diabetes mellitus (disorder), Diabetes mellitus, NOS, Diabetes NOS
French DIABETE SUCRE, Diabète sucré SAI, Diabète, Diabète sucré
Portuguese DIABETES MELLITUS, Diabetes, Diabetes mellitus NE, Diabete Melito, Diabetes Melito, Diabetes mellitus, Diabetes Mellitus
Spanish DIABETES MELLITUS, Diabetes, Diabetes mellitus NEOM, diabetes mellitus (trastorno), diabetes mellitus, diabetes sacarina, Diabetes mellitus, Diabetes Mellitus
German DIABETES MELLITUS, Diabetes, Diabetes mellitus NNB, Nicht naeher bezeichneter Diabetes mellitus, Diabetes mellitus
Dutch diabetes mellitus NAO, diabetes, diabetes mellitus, Niet gespecificeerde diabetes mellitus, Diabetes mellitus, Mellitus, diabetes, Suikerziekte
Italian Diabete, Diabete mellito NAS, Diabete mellito
Japanese 糖尿病, 糖尿病NOS, トウニョウビョウ, トウニョウビョウNOS
Swedish Diabetes
Czech diabetes mellitus, Diabetes, Diabetes mellitus, Diabetes mellitus NOS, cukrovka, DM, úplavice cukrová
Finnish Diabetes
Korean 상세불명의 당뇨병
Polish Cukrzyca
Hungarian Diabetes, Diabetes mellitus, Diabetes mellitus k.m.n.
Norwegian Diabetes, Diabetes mellitus, Sukkersyke